This view is supported by a study which reported that nitric oxide decreased P-selectin expression in vitro and in vivo [55] and by our clinical trial in which nitric oxide reduced pain scores in SCD patients with vaso-occlusive crisis [68]. This evidence concerns the gene SELP and Schnyder corneal dystrophy.